InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Friday, 06/15/2012 6:42:33 PM

Friday, June 15, 2012 6:42:33 PM

Post# of 995
Small capital network recommending VRML.
"Another featured stock of ours worth noting today is VRML. Shares of our suggested entry into VRML appear to be on the move again allowing us to have a second win in the stock in almost a month. The Company reported this morning that results of their recent Peripheral Artery Disease (PAD) multi-marker intended use study was presented this week at the Society for Vascular Medicine's 23rd Annual Scientific Sessions, in Minneapolis, MN. The meeting hosts the nation's leading vascular medicine specialists, and includes sessions on PAD guidelines, policy trends, and advances in the diagnosis and treatment of vascular diseases.
The poster is authored by Professor of Medicine and Associate Director of Stanford Cardiovascular Institute Dr. John Cooke, together with colleagues at the University of Colorado and is entitled "Results of a Biomarker Screen to Identify Peripheral Artery Disease." It reported the results of a multi-center clinical study involving 1,025 subjects, prospectively enrolled from the PAD at-risk population of subjects aged 70 or older, and diabetics and smokers 50 or older.
Different multi-marker algorithms were evaluated in patients with or without PAD, in comparison with the Framingham Risk Score (FRS). The multi-marker models were also assessed for their ability to identify PAD in patients below the high-risk FRS cutoff. The best model demonstrated a c-statistic of 0.73 and more important, identified 17 of 20 (85%) of patients missed by the FRS high-risk cutoff.
"Since one in every 20 Americans over the age of 50 has PAD(1), this study suggests the possibility for a simple and practical way to screen at-risk patients," said Dr. Cooke. "By detecting undiagnosed or asymptomatic PAD, primary care physicians can intervene earlier and improve the health and prognosis for their patients. We are truly excited at the confirmation our biomarker research achieved in this large group of at-risk subjects, and look forward to advancing our program."
It appears the market is loving the news as shares of VRML continue to trade higher today following the positive momentum of the stock over the last three days.
That's it for today. I have a strong feeling next week is going to be a big week for the market in terms of where it wants to go in the weeks and potentially months ahead, so stay tuned and have an excellent weekend.

Warmest Regards,
SmallCap Network
www.smallcapnetwork.com"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AWH News